Comparison of gene expression changes induced by biguanides in db/db mice liver

Journal of Toxicological Sciences

Volumn 33, Issue 3, 2008, Pages 339-347

  Heishi, Masayuki ^a   Hayashi, Koji ^a   Ichihara, Junji ^a   Ishikawa, Hironori ^a   Kawamura, Takao ^a   Kanaoka, Masaharu ^a   Taiji, Mutsuo ^a   Kimura, Toru ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

db db mouse; Metformin; Microarray; Phenformin

Indexed keywords

BIGUANIDE DERIVATIVE; GLUCOSE; METFORMIN; PHENFORMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOINFORMATICS; CELL DEATH; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; INFLAMMATION; LIVER; MALE; MOUSE; NONHUMAN; STRESS; WOUND;

MUS;

EID: 48849108755     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.33.339     Document Type: Article

References (21)

1. Allen-Jennings, A.E., Hartman, M.G., Kociba, G.J. and Hai, T. (2002): The roles of ATF3 in liver dysfunction and the regulation of phosphoenolpyruvate carboxykinase gene expression. J. Biol. Chem., 277, 20020-20025.
2. Arguni, E., Arima, M., Tsuruoka, N., Sakamoto, A., Hatano, M. and Tokuhisa, T. (2006): JunD/AP-1 and STAT3 are the major enhancer molecules for high Bcl6 expression in germinal center B cells. Int. Immunol., 18, 1079-1089.
3. Butte, A. (2002): The use and analysis of microarray data. Nat. Rev. Drug Discov., 1, 951-960.
4. Chan, N.N., Brain, H.P. and Feher, M.D. (1999): Metformin-associated lactic acidosis: a rare or very rare clinical entity? Diabet. Med., 16, 273-281.
5. Cryer, D.R., Nicholas, S.P., Henry, D.H., Mills, D.J. and Stadel, B.V. (2005): Comparative outcomes study of metformin intervention versus conventional approach the COSMIC Approach Study. Diabetes Care, 28, 539-543.
6. Dong, H., Toyoda, N., Yoneyama, H., Kurachi, M., Kasahara, T., Kobayashi, Y., Inadera, H., Hashimoto, S. and Matsushima, K. (2002): Gene expression profile analysis of the mouse liver during bacteria-induced fulminant hepatitis by a cDNA microarray system. Biochem. Biophys. Res. Commun., 298, 675-686.
7. Doniger, S.W., Salomonis, N., Dahlquist, K.D., Vranizan, K., Lawlor, S.C. and Conklin, B.R. (2003): MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol., 4, R7.
8. Draghici, S., Khatri, P., Martins, R.P., Ostermeier, G.C. and Krawetz, S.A. (2003): Global functional profiling of gene expression. Genomics, 81, 98-104.
9. Gitlin, J.D. (1998): Transcriptional regulation of ceruloplasmin gene expression during inflammation. J. Biol. Chem., 263, 6281-6287.
10. Heishi, M., Ichihara, J., Teramoto, R., Itakura, Y., Hayashi, K., Ishikawa, H., Gomi, H., Sakai, J., Kanaoka, M., Taiji, M. and Kimura, T. (2006): Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin. Diabetologia, 49, 1647-1655.
11. Ito, K., Kiyosawa, N., Kumagai, K., Manabe, S., Matsunuma, N. and Yamoto, T. (2006): Molecular mechanism investigation of cycloheximide-induced hepatocyte apoptosis in rat livers by morphological and microarray analysis. Toxicology, 219, 175-186.
12. Kwong, S.C. and Brubacher, J. (1998): Phenformin and lactic acidosis: a case report and review. J. Emerg. Med., 16, 881-886.
13. Lai, W.S., Thompson, M.J., Taylor, G.A., Liu, Y. and Blackshear, P.J. (1995): Promoter analysis of Zfp-36, the mitogen-inducible gene encoding the zinc finger protein tristetraprolin. J. Biol. Chem., 270, 25266-25272.
14. Luft, D., Schmülling, R.M. and Eggstein, M. (1978): Lactic acidosis in biguanide-treated diabetics: a review of 330 cases. Diabetologia, 14, 75-87.
15. McMullen, M.R., Pritchard, M.T., Wang, Q., Millward, C.A., Croniger, C.M. and Nagy, L.E. (2005): Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. Gastroenterology, 128, 2066-2076.
16. Peng, Y., Du, K., Ramirez, S., Diamond, R.H. and Taub, R. (1999): Mitogenic up-regulation of the PRL-1 protein-tyro sine phosphatase gene by Egr-1. Egr-1 activation is an early event in liver regeneration. J. Biol. Chem., 274, 4513-4520.
17. Salpeter, S.R., Greyber, E., Pasternak, G.A. and Salpeter, E.E. (2003): Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch. Intern. Med., 163, 2594-2602.
18. Seifert, M., Scherf, M., Epple, A. and Werner, T. (2005): Multievidence microarray mining. Trends Genet., 21, 553-558.
19. Stefanovic, L., Brenner, D.A. and Stefanovic, B. (2005): Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils. Exp. Biol. Med., 230, 573-586.
20. Sterne, J. (1969): Pharmacology and mode of action of the hypoglycaemic guanidine derivatives. In Oral Hypoglycaemic Agents (Campbell, G.D., ed.), pp.193-245, Academic Press, New York.
21. Ungar, G., Freedman, L. and Shapiro, S.L. (1957): Pharmacological studies of a new oral hypoglycemic drug. Proc. Soc. Exp. Biol. Med., 95, 190-192.